Advances in Antarctic Research for Antimicrobial Discovery: A Comprehensive Narrative Review of Bacteria from Antarctic Environments As Potential Sources of Novel Antibiotic Compounds Against Human Pathogens and Microorganisms of Industrial...
Overview
Affiliations
The recent emergence of antibiotic-resistant bacteria has become a critical public health problem. It is also a concern for industries, since multidrug-resistant microorganisms affect the production of many agricultural and food products of economic importance. Therefore, discovering new antibiotics is crucial for controlling pathogens in both clinical and industrial spheres. Most antibiotics have resulted from bioprospecting in natural environments. Today, however, the chances of making novel discoveries of bioactive molecules from various well-known sources have dramatically diminished. Consequently, unexplored and unique environments have become more likely avenues for discovering novel antimicrobial metabolites from bacteria. Due to their extreme polar environment, Antarctic bacteria in particular have been reported as a potential source for new antimicrobial compounds. We conducted a narrative review of the literature about findings relating to the production of antimicrobial compounds by Antarctic bacteria, showing how bacterial adaptation to extreme Antarctic conditions confers the ability to produce these compounds. We highlighted the diversity of antibiotic-producing Antarctic microorganisms, including the phyla Proteobacteria, Actinobacteria, Cyanobacteria, Firmicutes, and Bacteroidetes, which has led to the identification of new antibiotic molecules and supports the belief that research on Antarctic bacterial strains has important potential for biotechnology applications, while providing a better understanding of polar ecosystems.
Melissa B, Elisa B, Gabriella C, Maurizio A, Ombretta D, Andrea D Environ Microbiol. 2025; 27(2):e70045.
PMID: 39895061 PMC: 11788576. DOI: 10.1111/1462-2920.70045.
Going to extremes: progress in exploring new environments for novel antibiotics.
Quinn G, Dyson P NPJ Antimicrob Resist. 2025; 2(1):8.
PMID: 39843508 PMC: 11721673. DOI: 10.1038/s44259-024-00025-8.
Adaptation of clinical bacteriology techniques for remote polar research.
Pallett S, Kwok B, Wong S, Moore L Appl Environ Microbiol. 2025; 91(2):e0214724.
PMID: 39817735 PMC: 11837566. DOI: 10.1128/aem.02147-24.
Enhancing Antifungal Drug Discovery Through Co-Culture with Antarctic Strain CBMAI 1855.
Giordano A, Rodrigues M, Dos Santos K, Legabao B, Pontes L, de Angelis D Int J Mol Sci. 2024; 25(23).
PMID: 39684453 PMC: 11641416. DOI: 10.3390/ijms252312744.
Sermkaew N, Atipairin A, Krobthong S, Aonbangkhen C, Yingchutrakul Y, Uchiyama J Antibiotics (Basel). 2024; 13(9).
PMID: 39335020 PMC: 11428215. DOI: 10.3390/antibiotics13090846.